Kymera Therapeutics (KYMR) Cash from Financing Activities (2019 - 2026)
Kymera Therapeutics (KYMR) reported Cash from Financing Activities of $14.42 million for Q2 2026, down 94.1% from $245.73 million a year earlier and down 23.2% from the prior quarter.
Powered by 
Analysis
Kymera Therapeutics (KYMR) Cash from Financing Activities (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Kymera Therapeutics' Cash from Financing Activities came in at $777.92 million, up 55.7% year-over-year; for FY2025, it was $990.71 million, up 62.7% from FY2024.
- Cash from Financing Activities has a five-year compound annual growth rate of 27.9% (FY2020 to FY2025).
- By year, Cash from Financing Activities came in at $608.85 million in FY2024, $4.19 million in FY2023 (-97.3%), $153 million in FY2022 (-38.9%) and $250.28 million in FY2021 (-13.5%).
- The Q2 2026 figure ranks as the lowest quarterly Cash from Financing Activities since Q1 2025.
- Year over year, Cash from Financing Activities gained in 1 of the last four quarters, with an average decline of 58.8%.
- The high point for year-over-year Cash from Financing Activities in five years was Q4 2021 (growth of 660.7%); the low point was Q1 2025 (a decline of 99.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $18.77 million (Q1 2026), $705.22 million (Q4 2025) and $39.51 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Kymera Therapeutics | 9.25 Bn | 6.56 Bn | - | 14.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.42 Mn |
| Mar 31, 2026 | 18.77 Mn |
| Dec 31, 2025 | 705.22 Mn |
| Sep 30, 2025 | 39.51 Mn |
| Jun 30, 2025 | 245.73 Mn |
| Mar 31, 2025 | 258,000.00 |
| Dec 31, 2024 | 2.77 Mn |
| Sep 30, 2024 | 250.92 Mn |
| Jun 30, 2024 | 1.41 Mn |
| Mar 31, 2024 | 353.76 Mn |
| Dec 31, 2023 | 1.93 Mn |
| Sep 30, 2023 | -206,000.00 |
| Jun 30, 2023 | 1.31 Mn |
| Mar 31, 2023 | 1.16 Mn |
| Dec 31, 2022 | 1.95 Mn |
| Sep 30, 2022 | 150.50 Mn |
| Jun 30, 2022 | 364,000.00 |
| Mar 31, 2022 | 185,000.00 |
| Dec 31, 2021 | 2.05 Mn |
| Sep 30, 2021 | 246.04 Mn |
API Access
Kymera Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=KYMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "KYMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=KYMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();